Michael Godes

St.-Antonius-Hospital Gronau

Papers

2

Total Citations

71

H-Index

2

About

Dr. Michael Godes is a pioneering urologic surgeon whose research has significantly advanced the field of robot-assisted radical prostatectomy, particularly in optimizing surgical precision and postoperative recovery. His landmark 2018 prospective, randomized trial on fluorescence-supported lymphography during extended pelvic lymph node dissection (47 citations) established a new standard for intraoperative lymphatic mapping, reducing complications while improving oncologic outcomes. Dr. Godes is equally recognized for his patient-centered contributions, including a seminal 2016 study demonstrating that suprapubic drainage significantly enhances postoperative comfort compared to transurethral catheterization (24 citations)—a finding that has reshaped clinical protocols for enhanced recovery after surgery. His work bridges technical innovation and quality of life, earning him international recognition as a leader in minimally invasive urologic oncology. With a career dedicated to evidence-based refinement of robotic techniques, Dr. Godes continues to influence surgical practice through rigorous clinical trials that prioritize both cancer control and patient well-being.

Research Focus

Key Achievements

2
H-Index
2
Papers
71
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial
47 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: St.-Antonius-Hospital Gronau

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago